When cocultured with EMT6 tumor cells, Ly6C+CD8+ T-cell population showed significantly higher tumor cell killing activity compared with the Ly6C−CD8+ subset as demonstrated by increased annexin V staining and caspase 3 activity in the target tumor cells (Fig. 5f–i). The gene discussed is ANXA5; the disease is neoplasm.